Search - tctmd.com

Displaying 301 - 320 of 361

Sort: Relevancy | Date

Presentation TCT 2012

TCT-16. Renal Artery Nerve Distribution and Density in the Porcine Model: Biological Implications for the Development of Radiofrequency Ablation Therapies

Presenter: Armando Tellez

October 23, 2012

Presentation TCT 2012

TCT-10. Efficacy of Renal Denervation is Positively Impacted by Longitudinal Treatments

Presenter: Meital Mazor

October 23, 2012

Presentation TCT 2012

Essentials of Renal Artery Disease: Guidelines, Assessment, and Outcomes

Presenter: Jeffrey Olin

October 23, 2012

Presentation TCT 2012

Treating Fibromuscular Dysplasia in the Renal Artery

Presenter: Robert Lookstein

October 22, 2012

Presentation TCT 2012

Renal Sympathetic Denervation for HTN

Presenter: Lynne Hinterbuchner

October 22, 2012

Presentation TCT 2012

Diagnosis and Technical Management of Renal and Visceral Aneurysms

Presenter: Ripal Gandhi

October 22, 2012

Presentation TCT 2012

Debate II. Should Renal Artery Stenting Only Be Done Using FFR and IVUS? Pro!

Presenter: Mehdi Shishehbor

October 22, 2012

News Industry News

Vessix Vascular to Present 3-Month, 6-Month Results From REDUCE-HTN Renal Denervation Clinical Study at TCT

October 22, 2012

Presentation TCT 2012

Selecting the Patient Most Likely to Benefit from Renal Intervention

Presenter: Massoud Leesar

October 22, 2012

Presentation TCT 2012

Role of Renal Revascularization in 2012 and Predictions for the Future

Presenter: Michael Jaff

October 22, 2012

Presentation TCT 2012

Debate II. Should Renal Artery Stenting Only Be Done Using FFR and IVUS? Con!

Presenter: Christopher White

October 22, 2012

Presentation TCT 2012

Debate I. Is Embolic Protection Mandatory in Renal Artery Stenting? Pro!

Presenter: Michel Henry

October 22, 2012

Presentation TCT 2012

Debate I. Is Embolic Protection Mandatory in Renal Artery Stenting? Con!

Presenter: Christopher Cooper

October 22, 2012

Presentation TCT 2012

Avoiding Complications in Renal Artery Stenting: Lessons from a Master

Presenter: Mark Bates

October 22, 2012

News Daily News

La Dosis de Carga Doble de Clopidogrel No Ofrece Beneficio Alguno en Pacientes con ERC que se someten a PCI Primarias

L.A. McKeown

September 18, 2012

News Daily News

Double Clopidogrel Loading Dose Offers No Benefit in Primary PCI Patients with CKD

L.A. McKeown

September 18, 2012

Presentation VEINS 2012

Renal Denervation: A Percutaneous Therapy for HTN

Presenter: Nilesh J. Goswami

September 15, 2012

News Daily News

Un Modelo Sugiere que la Denervación Renal es Rentable contra la Hipertensión Resistente

September 13, 2012

News Daily News

Model Suggests Renal Denervation Cost-effective for Resistant Hypertension

September 13, 2012

Presentation

Cost-effectiveness and Clinical Effectiveness of Catheter-Based Renal Denervation for Resistant Hypertension

Presenter: B.P. Geisler

September 12, 2012

Advertisement

TCT-16. Renal Artery Nerve Distribution and Density in the Porcine Model: Biological Implications for the Development of Radiofrequency Ablation Therapies

TCT-10. Efficacy of Renal Denervation is Positively Impacted by Longitudinal Treatments

Essentials of Renal Artery Disease: Guidelines, Assessment, and Outcomes

Treating Fibromuscular Dysplasia in the Renal Artery

Renal Sympathetic Denervation for HTN

Diagnosis and Technical Management of Renal and Visceral Aneurysms

Debate II. Should Renal Artery Stenting Only Be Done Using FFR and IVUS? Pro!

Vessix Vascular to Present 3-Month, 6-Month Results From REDUCE-HTN Renal Denervation Clinical Study at TCT

Selecting the Patient Most Likely to Benefit from Renal Intervention

Role of Renal Revascularization in 2012 and Predictions for the Future

Debate II. Should Renal Artery Stenting Only Be Done Using FFR and IVUS? Con!

Debate I. Is Embolic Protection Mandatory in Renal Artery Stenting? Pro!

Debate I. Is Embolic Protection Mandatory in Renal Artery Stenting? Con!

Avoiding Complications in Renal Artery Stenting: Lessons from a Master

La Dosis de Carga Doble de Clopidogrel No Ofrece Beneficio Alguno en Pacientes con ERC que se someten a PCI Primarias

Double Clopidogrel Loading Dose Offers No Benefit in Primary PCI Patients with CKD

Renal Denervation: A Percutaneous Therapy for HTN

Un Modelo Sugiere que la Denervación Renal es Rentable contra la Hipertensión Resistente

Model Suggests Renal Denervation Cost-effective for Resistant Hypertension

Cost-effectiveness and Clinical Effectiveness of Catheter-Based Renal Denervation for Resistant Hypertension

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content